Editorial
Published on 12 Apr 2023
Editorial: Emerging talents in pharmacology of ion channels and channelopathies 2022
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1191328
- 1,166 views
Type at least 3 characters
519 articles
Articles
Review
Published on 31 Mar 2023
Endothelial KCa channels: Novel targets to reduce atherosclerosis-driven vascular dysfunction
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1151244
- 3,736 views
- 6 citations
Mini Review
Published on 27 Mar 2023
Real-world disparities and ethical considerations with access to CFTR modulator drugs: Mind the gap!
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1163391
- 8,131 views
- 26 citations
Original Research
Published on 27 Mar 2023
Differential effects of ELX/TEZ/IVA on organ-specific CFTR function in two patients with the rare CFTR splice mutations c.273+1G>A and c.165-2A>G
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1153656
- 2,069 views
- 3 citations
Review
Published on 22 Mar 2023
Therapeutic potential of TRPM8 channels in cancer treatment
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1098448
- 5,793 views
- 12 citations
Original Research
Published on 20 Mar 2023
Acute effect of antiseizure drugs on background oscillations in Scn1aA1783V Dravet syndrome mouse model
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1118216
- 2,705 views
- 3 citations
Original Research
Published on 16 Mar 2023
Molecular determinants of μ-conotoxin KIIIA interaction with the human voltage-gated sodium channel NaV1.7
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1156855
- 2,742 views
- 2 citations
Brief Research Report
Published on 08 Mar 2023
Early and sustained improvements of lung clearance index from two to sixteen weeks of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis—a real world study
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1125853
- 2,091 views
- 4 citations
Original Research
Published on 06 Mar 2023
Niclosamide does not modulate airway epithelial function through blocking of the calcium activated chloride channel, TMEM16A
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1142342
- 2,354 views
- 10 citations
Original Research
Published on 27 Feb 2023
Kv7-specific activators hyperpolarize resting membrane potential and modulate human iPSC-derived sensory neuron excitability
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1138556
- 3,404 views
- 1 citation
Original Research
Published on 24 Feb 2023
Patch clamp studies on TRPV4-dependent hemichannel activation in lens epithelium
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1101498
- 1,871 views
- 2 citations
Editorial
Published on 01 Feb 2023
Editorial: Targeting pumps, channels and transporters for the treatments of vascular, cardiovascular and kidney diseases
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1130882
- 1,142 views
Original Research
Published on 27 Jan 2023
Changes in cystic fibrosis transmembrane conductance regulator protein expression prior to and during elexacaftor-tezacaftor-ivacaftor therapy
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1114584
- 3,542 views
- 8 citations
Original Research
Published on 21 Dec 2022
Cyclovirobuxine D, a cardiovascular drug from traditional Chinese medicine, alleviates inflammatory and neuropathic pain mainly via inhibition of voltage-gated Cav3.2 channels
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1081697
- 2,956 views
- 8 citations
Original Research
Published on 21 Dec 2022
A KCNB1 gain of function variant causes developmental delay and speech apraxia but not seizures
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1093313
- 2,972 views
- 9 citations
Original Research
Published on 16 Dec 2022
Ameliorative effects of omega-lycotoxin-Gsp2671e purified from the spider venom of Lycosa praegrandis on memory deficits of glutamate-induced excitotoxicity rat model
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1048563
- 2,330 views
- 4 citations